Published in J Mol Biol on August 20, 2009
Net charge per residue modulates conformational ensembles of intrinsically disordered proteins. Proc Natl Acad Sci U S A (2010) 2.16
Critical nucleus size for disease-related polyglutamine aggregation is repeat-length dependent. Nat Struct Mol Biol (2011) 1.60
Opposing effects of glutamine and asparagine govern prion formation by intrinsically disordered proteins. Mol Cell (2011) 1.49
Unmasking the roles of N- and C-terminal flanking sequences from exon 1 of huntingtin as modulators of polyglutamine aggregation. Proc Natl Acad Sci U S A (2013) 1.39
Physical chemistry of polyglutamine: intriguing tales of a monotonous sequence. J Mol Biol (2012) 1.37
Modulation of polyglutamine conformations and dimer formation by the N-terminus of huntingtin. J Mol Biol (2009) 1.30
Slow amyloid nucleation via α-helix-rich oligomeric intermediates in short polyglutamine-containing huntingtin fragments. J Mol Biol (2011) 1.17
Polyglutamine induced misfolding of huntingtin exon1 is modulated by the flanking sequences. PLoS Comput Biol (2010) 1.17
Assessing the contribution of heterogeneous distributions of oligomers to aggregation mechanisms of polyglutamine peptides. Biophys Chem (2011) 1.13
Describing sequence-ensemble relationships for intrinsically disordered proteins. Biochem J (2013) 1.00
β-hairpin-mediated nucleation of polyglutamine amyloid formation. J Mol Biol (2013) 0.96
Structural motif of polyglutamine amyloid fibrils discerned with mixed-isotope infrared spectroscopy. Proc Natl Acad Sci U S A (2014) 0.91
UV resonance Raman spectroscopy monitors polyglutamine backbone and side chain hydrogen bonding and fibrillization. Biochemistry (2012) 0.91
Autophagy proteins play cytoprotective and cytocidal roles in leucine starvation-induced cell death in Saccharomyces cerevisiae. Autophagy (2012) 0.90
Trinucleotide repeats: a structural perspective. Front Neurol (2013) 0.89
Probing the disordered domain of the nuclear pore complex through coarse-grained molecular dynamics simulations. Biophys J (2014) 0.87
Elongation kinetics of polyglutamine peptide fibrils: a quartz crystal microbalance with dissipation study. J Mol Biol (2012) 0.84
Dynamic imaging by fluorescence correlation spectroscopy identifies diverse populations of polyglutamine oligomers formed in vivo. J Biol Chem (2012) 0.84
A coarse-grained model for polyglutamine aggregation modulated by amphipathic flanking sequences. Biophys J (2014) 0.84
Aggregation kinetics of interrupted polyglutamine peptides. J Mol Biol (2011) 0.84
Understanding protein aggregation from the view of monomer dynamics. Mol Biosyst (2012) 0.83
CHARMM36m: an improved force field for folded and intrinsically disordered proteins. Nat Methods (2016) 0.83
A platform to view huntingtin exon 1 aggregation flux in the cell reveals divergent influences from chaperones hsp40 and hsp70. J Biol Chem (2013) 0.82
Are long-range structural correlations behind the aggregration phenomena of polyglutamine diseases? PLoS Comput Biol (2012) 0.81
Novel polyglutamine model uncouples proteotoxicity from aging. PLoS One (2014) 0.80
Fibrillogenesis of huntingtin and other glutamine containing proteins. Subcell Biochem (2012) 0.79
Evaluation of Nanoparticle Tracking for Characterization of Fibrillar Protein Aggregates. AIChE J (2014) 0.79
An Analysis of Biomolecular Force Fields for Simulations of Polyglutamine in Solution. Biophys J (2015) 0.78
Polyglutamine aggregates impair lipid membrane integrity and enhance lipid membrane rigidity. Biochim Biophys Acta (2016) 0.78
An Intein-based Strategy for the Production of Tag-free Huntingtin Exon 1 Proteins Enables New Insights into the Polyglutamine Dependence of Httex1 Aggregation and Fibril Formation. J Biol Chem (2016) 0.76
Solvation Thermodynamics of Oligoglycine with Respect to Chain Length and Flexibility. Biophys J (2016) 0.76
The emerging role of the first 17 amino acids of huntingtin in Huntington's disease. Biomol Concepts (2015) 0.76
The Protein Structure Context of PolyQ Regions. PLoS One (2017) 0.75
Sequence-dependent stability test of a left-handed β-helix motif. Biophys J (2012) 0.75
Backbone engineering within a latent β-hairpin structure to design inhibitors of polyglutamine amyloid formation. J Mol Biol (2016) 0.75
Structure prediction of polyglutamine disease proteins: comparison of methods. BMC Bioinformatics (2014) 0.75
Conformational properties of polyglutamine sequences in guanidine hydrochloride solutions. Biophys J (2012) 0.75
Q&A: repeat-containing proteins. Nat Struct Mol Biol (2015) 0.75
Folding-unfolding transitions in single titin molecules characterized with laser tweezers. Science (1997) 10.17
Resonance energy transfer: methods and applications. Anal Biochem (1994) 4.99
Huntington's disease age-of-onset linked to polyglutamine aggregation nucleation. Proc Natl Acad Sci U S A (2002) 3.56
Polyproline and the "spectroscopic ruler" revisited with single-molecule fluorescence. Proc Natl Acad Sci U S A (2005) 3.01
Polyglutamine aggregation behavior in vitro supports a recruitment mechanism of cytotoxicity. J Mol Biol (2001) 2.80
Huntingtin aggregation and toxicity in Huntington's disease. Lancet (2003) 2.72
Polyglutamine pathogenesis: emergence of unifying mechanisms for Huntington's disease and related disorders. Neuron (2002) 2.67
Polyglutamine neurodegeneration: protein misfolding revisited. Trends Neurosci (2008) 2.63
Amyloid-like features of polyglutamine aggregates and their assembly kinetics. Biochemistry (2002) 2.59
Molecular genetics: unmasking polyglutamine triggers in neurodegenerative disease. Nat Rev Neurosci (2000) 2.44
Aggregated polyglutamine peptides delivered to nuclei are toxic to mammalian cells. Hum Mol Genet (2002) 2.44
A toxic monomeric conformer of the polyglutamine protein. Nat Struct Mol Biol (2007) 2.33
End-to-end distance distributions and intrachain diffusion constants in unfolded polypeptide chains indicate intramolecular hydrogen bond formation. Proc Natl Acad Sci U S A (2006) 2.23
Ectopically expressed CAG repeats cause intranuclear inclusions and a progressive late onset neurological phenotype in the mouse. Cell (1997) 2.13
Solubilization and disaggregation of polyglutamine peptides. Protein Sci (2001) 2.00
Fluorescence correlation spectroscopy shows that monomeric polyglutamine molecules form collapsed structures in aqueous solutions. Proc Natl Acad Sci U S A (2006) 2.00
Polyglutamine diseases: emerging concepts in pathogenesis and therapy. Hum Mol Genet (2007) 1.95
A potent small molecule inhibits polyglutamine aggregation in Huntington's disease neurons and suppresses neurodegeneration in vivo. Proc Natl Acad Sci U S A (2005) 1.88
Solution structure of polyglutamine tracts in GST-polyglutamine fusion proteins. FEBS Lett (2002) 1.78
Soluble polyglutamine oligomers formed prior to inclusion body formation are cytotoxic. Hum Mol Genet (2007) 1.66
polyglutamine aggregation nucleation: thermodynamics of a highly unfavorable protein folding reaction. Proc Natl Acad Sci U S A (2005) 1.57
Polymer models of protein stability, folding, and interactions. Biochemistry (2004) 1.57
Sensitive biochemical aggregate detection reveals aggregation onset before symptom development in cellular and murine models of Huntington's disease. J Neurochem (2007) 1.54
Cooperative effects of cofilin (ADF) on actin structure suggest allosteric mechanism of cofilin function. J Mol Biol (2005) 1.50
Failure of Energy Transfer between Identical Aromatic Molecules on Excitation at the Long Wave Edge of the Absorption Spectrum. Proc Natl Acad Sci U S A (1970) 1.46
Atomistic simulations of the effects of polyglutamine chain length and solvent quality on conformational equilibria and spontaneous homodimerization. J Mol Biol (2008) 1.43
Beyond the Qs in the polyglutamine diseases. Genes Dev (2001) 1.41
Effects of denaturants on the dynamics of loop formation in polypeptides. Biophys J (2006) 1.39
Conformational distribution of a 14-residue peptide in solution: a fluorescence resonance energy transfer study. J Phys Chem B (2005) 1.35
Reconsidering the mechanism of polyglutamine peptide aggregation. Biochemistry (2007) 1.31
Pathogenic and non-pathogenic polyglutamine tracts have similar structural properties: towards a length-dependent toxicity gradient. J Mol Biol (2007) 1.31
Random coil conformation for extended polyglutamine stretches in aqueous soluble monomeric peptides. J Pept Res (1997) 1.30
Effect of acid predissolution on fibril size and fibril flexibility of synthetic beta-amyloid peptide. Biophys J (1994) 1.28
Neurodegeneration. A glutamine-rich trail leads to transcription factors. Science (2002) 1.26
Single homopolypeptide chains collapse into mechanically rigid conformations. Proc Natl Acad Sci U S A (2009) 1.25
Structural and functional analysis of ataxin-2 and ataxin-3. Eur J Biochem (2004) 1.24
Protein aggregation and pathogenesis of Huntington's disease: mechanisms and correlations. Biol Chem (2001) 1.23
Normal-repeat-length polyglutamine peptides accelerate aggregation nucleation and cytotoxicity of expanded polyglutamine proteins. Proc Natl Acad Sci U S A (2006) 1.21
Nucleocytoplasmic trafficking and transcription effects of huntingtin in Huntington's disease. Prog Neurobiol (2007) 1.12
Kinetics of interior loop formation in semiflexible chains. J Chem Phys (2006) 1.08
Thermodynamics of beta-sheet formation in polyglutamine. Biophys J (2009) 1.07
Identification of anti-prion compounds as efficient inhibitors of polyglutamine protein aggregation in a zebrafish model. J Biol Chem (2006) 1.03
Effects of chain length on the aggregation of model polyglutamine peptides: molecular dynamics simulations. Proteins (2007) 1.03
Model discrimination and mechanistic interpretation of kinetic data in protein aggregation studies. Biophys J (2009) 1.02
Interaction of alpha-dansylated peptide inhibitors with porcine pepsin: detection of complex formation by fluorescence energy transfer and chromatography and evidence for a two-step binding scheme. Biochemistry (1981) 0.99
Conformation of prion protein repeat peptides probed by FRET measurements and molecular dynamics simulations. Biophys J (2004) 0.99
The intrinsic stiffness of polyglutamine peptides. J Phys Chem B (2008) 0.91
Kinetics of contact formation and end-to-end distance distributions of swollen disordered peptides. Biophys J (2009) 0.90
Reconsidering the mechanism of polyglutamine peptide aggregation. Biochemistry (2007) 1.31
Model discrimination and mechanistic interpretation of kinetic data in protein aggregation studies. Biophys J (2009) 1.02
Inhibition of insulin fibrillogenesis with targeted peptides. Protein Sci (2006) 0.99
Affinity-based inhibition of beta-amyloid toxicity. Biochemistry (2002) 0.99
Kinetics of inhibition of beta-amyloid aggregation by transthyretin. Biochemistry (2006) 0.98
Characterization of the interaction of β-amyloid with transthyretin monomers and tetramers. Biochemistry (2010) 0.95
Phage display affords peptides that modulate beta-amyloid aggregation. J Am Chem Soc (2006) 0.94
Identification of beta-amyloid-binding sites on transthyretin. Protein Eng Des Sel (2012) 0.91
Length-dependent aggregation of uninterrupted polyalanine peptides. Biochemistry (2011) 0.91
Transthyretin as both a sensor and a scavenger of β-amyloid oligomers. Biochemistry (2013) 0.88
Kinetics of adsorption of beta-amyloid peptide Abeta(1-40) to lipid bilayers. J Biochem Biophys Methods (2003) 0.86
Targeted control of kinetics of beta-amyloid self-association by surface tension-modifying peptides. J Biol Chem (2003) 0.86
Design of peptidyl compounds that affect beta-amyloid aggregation: importance of surface tension and context. Biochemistry (2005) 0.85
Mechanism of accelerated assembly of beta-amyloid filaments into fibrils by KLVFFK(6). Biophys J (2004) 0.84
Elongation kinetics of polyglutamine peptide fibrils: a quartz crystal microbalance with dissipation study. J Mol Biol (2012) 0.84
Aggregation kinetics of interrupted polyglutamine peptides. J Mol Biol (2011) 0.84
Urea modulation of beta-amyloid fibril growth: experimental studies and kinetic models. Protein Sci (2004) 0.84
Transthyretin-derived peptides as β-amyloid inhibitors. ACS Chem Neurosci (2014) 0.82
Differential modification of Cys10 alters transthyretin's effect on beta-amyloid aggregation and toxicity. Protein Eng Des Sel (2009) 0.82
Structural characterization of apomyoglobin self-associated species in aqueous buffer and urea solution. Biophys J (2005) 0.80
Location trumps length: polyglutamine-mediated changes in folding and aggregation of a host protein. Biophys J (2011) 0.78
Predicting solvent and aggregation effects of peptides using group contribution calculations. Biotechnol Prog (2006) 0.78
Synthesis and disaggregation of asparagine repeat-containing peptides. J Pept Sci (2014) 0.77
Insights into the molecular mechanism of protein native-like aggregation upon glycation. Biochim Biophys Acta (2012) 0.77
A strategy for generating polyglutamine 'length libraries' in model host proteins. Protein Eng Des Sel (2008) 0.77